Previous Statements by IDXX
» IDEXX Laboratories' CEO Discusses Q2 2011 Results - Earnings Call Transcript
» IDEXX Laboratories Inc. Q4 2008 Earnings Call Transcript
» IDEXX Laboratories, Inc. Q2 2008 Earnings Call Transcript
Cramer can't understand why shares of Johnson Controls spinoff Adient aren't trading higher.
Going into earnings what the market needs now is more negativity, Cramer says.
The Mars-VCA deal is yet another sign that pet health is a robust business.